These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6352635)

  • 1. Treatment of lower respiratory tract infections with ceftazidime.
    Pettersson T; Storgårds E; Ahvonen P
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():31-4. PubMed ID: 6352635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftazidime in severe infections: a Swiss multicentre study.
    Francioli P; Clément M; Geroulanos S; von Graevenitz A; Luthy R; Regamey C; Stalder H; Vogt M; Waldvogel FA
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():139-46. PubMed ID: 6225761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftazidime in the treatment of lower respiratory tract infection.
    Peirce TH; Vig SJ; Ingram PM
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():21-5. PubMed ID: 6352621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience in the treatment of lower respiratory tract infections with ceftazidime.
    Pettersson T; Ahvonen P; Storgårds E
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():303-5. PubMed ID: 19803003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The French experience with moxalactam in pneumology].
    Leng B; Imbert Y; Coomans D
    Sem Hop; 1983 Jun; 59(26):1977-80. PubMed ID: 6310790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of cefepime versus ceftazidime in the treatment of severe infections.
    Huang CK; Chen YS; Lee SS; Lin WR; Tsai HC; Lin HH; Wann SR; Chen JY; Yen MY; Liu YC
    J Microbiol Immunol Infect; 2002 Sep; 35(3):159-67. PubMed ID: 12380788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the efficacy of ceftazidime versus cefazolin and tobramycin in patients with acute exacerbations of chronic bronchitis.
    Vetter N; Feist H; Muhar F; Williams KJ
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():35-9. PubMed ID: 6352642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftazidime therapy for serious infections.
    Bint AJ; Constable J; Patton KR; Constable FL
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():115-21. PubMed ID: 6352613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of ceftazidime in the treatment of severe localized and systemic infections.
    Gabrielli GB; Corrocher R; De Sandre G
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):167-9. PubMed ID: 6370875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of cefepime (BMY-28142) and ceftazidime for the treatment of pneumonia.
    Edelstein H; Chirurgi V; Oster S; Karp R; Cassano K; Aiken S; McCabe R
    J Antimicrob Chemother; 1991 Oct; 28(4):569-75. PubMed ID: 1761451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic and recurrent respiratory infections with intramuscular ceftazidime.
    Davies BI; Maesen FP; van Noord JA
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():1-8. PubMed ID: 6352611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of lower respiratory tract infections with cefoperazone.
    Kaplowitz LG; Sarubbi FA
    Clin Ther; 1983; 5(3):243-50. PubMed ID: 6221798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime in patients with Pseudomonas infections.
    Eron LJ; Park CH; Hixon DL; Goldenberg RI; Poretz DM
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():161-9. PubMed ID: 6225762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of ceftriaxone versus ceftazidime in the treatment of nosocomial lower respiratory tract infections.
    Bassetti D; Cruciani M; Solbiati M; Rubini F; Gandola L; Valenti G; De Palma M; Corda R; Carimeo N
    Chemotherapy; 1991; 37(5):371-5. PubMed ID: 1804598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftazidime in the therapy of serious Gram-negative bacillary infections.
    Pottage JC; Karakusis PH; Fliegelman RM; Levin S; Trenholme GM
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():223-8. PubMed ID: 6352623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of severe lower respiratory tract infections with ceftriaxone (Ro 13-9904). A pilot study.
    Keller R; Humair L
    Chemotherapy; 1981; 27 Suppl 1():93-9. PubMed ID: 7249798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cefotaxime in bronchopulmonary infections (author's transl)].
    Kermarec J; Sauvaget J
    Nouv Presse Med; 1981 Feb; 10(8):650-3. PubMed ID: 6259612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of ceftazidime in the field of pediatrics].
    Koshinami M; Watanabe A
    Jpn J Antibiot; 1984 Mar; 37(3):344-8. PubMed ID: 6376847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical studies on ceftazidime in the pediatric field].
    Aoyama R; Waga S; Ohnishi A; Izumi Y; Kuronuma T; Kakizaki Y; Nagata K; Kudo M; Okaniwa S; Sawaguchi H
    Jpn J Antibiot; 1984 Mar; 37(3):349-54. PubMed ID: 6376848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
    Colardyn F
    J Chemother; 1995 Jun; 7 Suppl 2():129-35. PubMed ID: 8622101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.